文献速递乳腺外科

机器人辅助保乳手术首项多中心研究:KoREa-BSG 组经验

The first multicenter study of robot-assisted breast-conserving surgery: insights from the KoREa-BSG group.
PubMed 文献 · Surg Endosc · 2025-08-11

结果显示该技术可行且安全,中转开放手术和死亡均为零,但需进一步前瞻性对照研究评估患者满意度、成本效益及长期肿瘤学结局。

要点

  • 机器人辅助保乳手术在 150 例多中心队列中可行且安全,无中转开放手术和死亡。
  • 术后并发症 4%,其中皮肤烧伤 5 例(3.3%)、术后出血 1 例。

核心结论

  • 这是首项机器人辅助保乳手术的多中心报告,提示该技术可行且安全。
  • 需进一步开展对比性和前瞻性研究评估患者满意度、成本效益及长期外科与肿瘤学结局。

研究设计与样本

  • 收集临床病理特征、围术期并发症、手术时间、复发及再手术信息。

主要发现

  • 浸润性乳腺癌 121 例,导管原位癌 29 例。
  • 雌激素受体阳性 75.3%,孕激素受体阳性 65.3%,HER2 阳性 35.3%。
  • Da Vinci SP 系统使用更频繁(60%),充气法应用 97.33%,前哨淋巴结活检为最常见腋窝手术(89.3%)。
  • 中位术后住院日 5.4 天,切口位于腋中线,中位切口长度 37.1 mm,中位总手术时间 133.8 min。

临床怎么用

  • 机器人辅助保乳手术可作为部分乳腺癌患者保乳手术的可行选择,需注意皮肤烧伤等并发症。
  • 术中冰冻切缘阳性率 7.3%,但仅 0.7% 需因永久切缘阳性再手术,提示需规范切缘评估流程。
  • 该技术的中转开放手术率和死亡率均为零,但长期肿瘤学结局尚待前瞻性研究确认。

局限性

  • 本研究为多中心回顾性综述,非前瞻性对照设计。
  • 缺乏与传统保乳手术的对比数据。
  • 患者满意度、成本效益及长期外科与肿瘤学结局尚未评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Robot-assisted breast-conserving surgery has a potentially better cosmetic benefit than conventional breast-conserving surgery without any scarring on the breast. However, data on the feasibility and safety are limited. This study presents the results of early robot-assisted breast-conserving surgery. METHODS: A multi-center retrospective review was conducted to identify women who underwent robot-assisted breast- conserving surgery between August 2019 and October 2023. Information on the clinicopathological characteristics, perioperative complications, operation time, recurrence, and reoperation was collected. RESULTS: A total of 150 patients underwent the surgery performed by ten breast surgeons at seven institutions. Invasive breast cancer was observed in 121 cases and ductal carcinoma in situ was detected in 29 cases. Of all the patients, 75.3% and 65.3% had an estrogen and progesterone receptor positive status, respectively. A total of 35.3% of the patients had a HER2-positive status. In terms of the surgical technique, the Da Vinci SP system was more frequently used (60%). Gas insufflation was applied in 97.33% of the cases, and sentinel lymph node biopsy was the most common axillary surgery (89.3%). The median postoperative days was 5.4 days. The incision location was the mid-axillary line, and the median incision length was 37.1 mm. The median total operation time was 133.8 min. Eleven cases (7.3%) had positive frozen margins, and only one case (0.7%) required reoperation because of permanent positive margin. Six patients (4%) developed surgical complications. Postoperative bleeding was found in one case and skin burns were found in five cases (3.3%). There were no cases of conversion to open surgery or of mortality. Two patient (1.3%) had recurrence. CONCLUSIONS: This is the first multicenter report on robot-assisted breast-conserving surgery, suggesting the technique is feasible and safe. Further comparative and prospective studies are warranted to evaluate patient satisfaction, cost-effectiveness, and long-term surgical and oncological outcomes.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Choi HJ, Paek SH, Lee JH, et al. The first multicenter study of robot-assisted breast-conserving surgery: insights from the KoREa-BSG group. Surg Endosc. 2025. PMID: 40789780. doi:10.1007/s00464-025-11964-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。